《国际糖尿病》：二甲双胍通常被看作是胰岛素增敏剂。在改善胰岛素抵抗方面，二甲双胍和吡格列酮的区别有哪些？
International Diabetes: metformin is often viewed as an insulin sensitizer. What is the difference between metformin and pioglitazone with regard to improving insulin resistance?
吡格列酮联用磺脲类、胰岛素或者二甲双胍用于8项试验(8501个病人)。
Pioglitazone was tested in combination with a sulfonylurea, insulin, or metformin in 8 trials (8501 patients).
目的了解胰岛素联合罗格列酮或二甲双胍治疗对2型糖尿病患者血清脂联素水平及体脂分布的影响。
Objective To study the effects of insulin plus rosiglitazone and insulin plus metformin on serum adiponectin and body fat distribution in type 2 diabetes mellitus.
目的：观察溴隐停、二甲双胍、罗格列酮分别对多囊卵巢综合征(PCOS)大鼠胰岛素抵抗、血脂和氧化应激作用。
Objective: To investigate the effects of bromocriptine and rosiglitazone and metformin on insulin resistance metabolism of lipids and oxidative stress in rats with polycystic ovary syndrome (PCOS).
二甲双胍和吡格列酮都是胰岛素增敏剂，因此这两类药物不会导致低血糖，而GLP-1类似物或DPP-IV抑制剂导致低血糖的概率也很低。
The metformin and pioglitazone are insulin sensitizers so they never lower you blood glucose below normal and the GLP-1 analogues or DPP-IV inhibitors also never lower your blood glucose below normal.
二甲双胍和吡格列酮都是胰岛素增敏剂，因此这两类药物不会导致低血糖，而GLP-1类似物或DPP-IV抑制剂导致低血糖的概率也很低。
The metformin and pioglitazone are insulin sensitizers so they never lower you blood glucose below normal and the GLP-1 analogues or DPP-IV inhibitors also never lower your blood glucose below normal.
应用推荐